Cancer cells can gain resistance against cell death, e.g. by overexpressing proteins that suppress IP3R-mediated Ca2+ signaling, like Akt78, or by increasing the intermembrane distance at the MAMs (e.g. FATE1), thereby rendering ER–mitochondrial Ca2+ transfer less efficient61. This evidence concerns the gene ITPR3 and cancer.